Marijuana Chemicals Ease MS Symptoms, Review Confirms

    Delta9-tetrahydrocannabinol (THC) and cannabidiol (CBD) — two of the key ingredients of marijuana — are effective in reducing spasticity and improving mobility among patients with multiple sclerosis (MS), according to a new research review.

    eScience News reported Dec. 3 that researchers from the Global Neuroscience Initiative Foundation conducted a review of previously published research studies and concluded that THC and CBD extracts were effective treatments for MS symptoms, albeit with side-effects like intoxication.

    “Considering the distress and limitations spasticity brings to individuals with MS, it is important to carefully weigh the potential for side effects with the potential for symptom relief,” said researcher Shaheen Lakhan. “The therapeutic potential of cannabinoids in MS is comprehensive and should be given considerable attention.”

    The review was published in the journal BMC Neurology.

    By Partnership Staff
    December 2009


    December 2009


    Sign up to join our community working to end addiction.

    Please leave this field empty

    By entering your email address above you are opting in to receive email communications from Partnership to End Addiction and agreeing to our Terms of Use and Privacy Policy.

    No, thanks. Take me to the website.